{{ user.firstName }} {{ user.lastName }}

ESO-WSO 2020 Large Clinical Trials Results available to view

With travel restricted due to the COVID-19 pandemic, the ESO-WSO 2020 Large Clinical Trials Results have been made available to watch in the comfort of your own home.

The webinar was held on 13 May and presented the results from 5 large clinical trials in the field of stroke care:

  • EFFECTS Trial
    Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke
    Assoc. Prof. Erik Lundström (Sweden) Department of Neuroscience, Neurology, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden
  • AFFINITY Trial
    Assessment of Fluoxetine in Stroke Recovery: Results of a Double-blind, Placebo-controlled, Randomised Trial
    Prof. Graeme Hankey (Australia) Department of Neurology, Medical School, Faculty of Health and Medical Sciences, The University of Western Australia
  • DIRECT-MT Trial
    A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectomy Preceded by Intravenous Alteplase in Acute Ischemic Stroke
    Prof. Jianmin Liu (China) Changhai Hospital in Shanghai, Department of Neurosurgery, Cerebrovascular Centre, China
  • BASICS Trial
    The Basilar Artery International Collaboration Study: A Randomized Controlled Trial of Endovascular Therapy in Basilar Artery Occlusion
    Dr Wouter Schonewille (Netherlands) Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands
  • ASCOT Trial
    The Effect of Randomisation to Atorvastatin or Placebo, and Amlodipine-based or Beta-blocker-based Regime on 20-year Incidence of Stroke or Dementia
    Dr William Whiteley (UK) Senior Lecturer, CCBS, University of Edinburgh, Honorary Consultant Neurologist, NHS Lothian, Senior Clinical Fellow, NDPH, University of Oxford

Access to these presentations is free and no pre-registration is required.

Watch them at eso-wso-conference.org/eso-wso-may-webinar